Inventor
SAUER ACHIM
DE18 patents
⚠️ This page may combine multiple inventors who share the name “SAUER ACHIM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BOEHRINGER INGELHEIM INT
6 patentsUS7776830B2Aug 17, 2010
Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture
BOEHRINGER INGELHEIM INT71 citations98
US7745414B2Jun 29, 2010
Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture
BOEHRINGER INGELHEIM INT72 citations98
US8048899B2Nov 1, 2011
Compounds which selectively modulate the CB2 receptor
BOEHRINGER INGELHEIM INT40 citations95
US8362039B2Jan 29, 2013
Therapeutic uses of compounds which selectively modulate the CB2 receptor
BOEHRINGER INGELHEIM INT17 citations91
US8349871B2Jan 8, 2013
Therapeutic uses of compounds which selectively modulate the CB2 receptor
BOEHRINGER INGELHEIM INT15 citations91
US10329292B2Jun 25, 2019
Substituted xanthine derivatives
BOEHRINGER INGELHEIM INT0 citations51
CENTREXION THERAPEUTICS CORP
6 patentsUS10570125B2Feb 25, 2020
(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles
CENTREXION THERAPEUTICS CORP4 citations83
US10112934B2Oct 30, 2018
(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles
CENTREXION THERAPEUTICS CORP4 citations83
US9650370B2May 16, 2017
(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles
CENTREXION THERAPEUTICS CORP5 citations81
US11725004B2Aug 15, 2023
(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles
CENTREXION THERAPEUTICS CORP1 citations72
US11084810B2Aug 10, 2021
(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles
CENTREXION THERAPEUTICS CORP2 citations72
US12344601B2Jul 1, 2025
(cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles
CENTREXION THERAPEUTICS CORP0 citations59